First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study. 18. November 2021 Dechow T, Riera-Knorrenschild J, Hackanson B, Janssen J, Schulz H, Chiabudini M, Fischer von Weikersthal L, Budweiser S, Nacke A, Taeuscher D, Welslau M, Potthoff K, 2021 Cancer Medicine, Volume 10, Issue 22, p. 8127-8137, 2021. http://doi.org/10.1002/cam4.4310 Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO. Zaiss M, Uhlig J, Zahn MO, Decker T, Lehmann HC, Harde J, Hogrefe C, Vannier C, Marschner N, 2021. Oncol Res Treat. 2021;44(11):613-621. doi:… Weiterlesen First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study. Müller V, Ruhnke M, Hoffmann O, Grafe A, Tomé O, Fett W, Bruch HR, Sommer-Joos AK, Schneeweiss A, 2021. The Breast, Volume 60, P70-77,… Weiterlesen